NCT01319370 - Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Androgenetic Alopecia

Interventions

DRUG

Minoxidil

1 g of 5% Minoxidil topical foam twice daily over 24 weeks in double-blinded phase and further 80 weeks in open-label-phase

DRUG

vehicle of 5% Minoxidil topical foam

1 g of vehicle topical foam twice daily over 24 weeks in double-blinded phase and further 80 weeks in open-label-phase

Trial Locations (1)

Charité-Universitätsmedizin Berlin, Clinical Research Center for Hair and Skin Science, Dept. of Dermatology, Venereology and Allergy, Berlin